You can narrow down the results using the filters
-
How is protein metabolism perturbed by long-term glucocorticoid use?
Expand descriptionLong-term glucocorticoid use causes substantial morbidity from protein loss. The aim was to determine how protein metabolism was perturbed in long-term glucocorticoid users.
-
Impact of short-term low dose glucocorticoids on protein metabolism
Expand descriptionThe aim of this study is to determine if short-term low dose glucocorticoids alters protein metabolism in a way that results in protein loss. This information will help in the development of therapies that reverse or prevent protein loss in patients requiring long-term glucocorticoids.
-
A Phase II trial of cellular immunotherapy on CA-125 response with M-FP cancer vaccine in patients with epithelial ovarian carcinoma
Expand description -
Use of a CO2 clamp and or CPAP to stabilize respiration in patients with combined central and obstructive sleep apnoea
Expand description -
Treatment of Resistant Command Hallucinations
Expand description -
Open versus Laparoscopic Burch colposuspension: a randomised controlled trial.
Expand description -
A Phase l Study to Determine the Pharmacokinetics of Testosterone from a Metered Dose Transdermal System (MDTS) in low libido in post-menopausal women suffering from low serum testosterome
Expand description -
Bi-level Ventilatory Support during exacerbations of Cystic Fibrosis
Expand descriptionThis trial was completed recruitment in 2006 and data collection (for time-to-next readmission in 2015. Manuscript was published in the Journal of Physiotherapy 2015, vol 61:142-147.
-
Virological and clinical anti-HBV efficacy of tenofovir in antiretroviral naive patients with HIV/HBV co-infection
Expand descriptionA randomised multi-centre trial of tenofovir vs lamivudine vs tenofovir/lamivudine in antiretroviral naive subjects with HIV/HBV co-infection over 48 weeks (Clinical Trial A). Plus, a 12 week viral kinetic sub-study comparing a sub-group of the patients on Clinical Trial A with a group of therapy naive HBV mono-infected subjects (Substudy A1)
-
Australian Trial in Acute Hepatitis C
Expand descriptionA prospective non-randomised dual arm longitudinal cohort of newly acquired hepatitis C infection into which participants will be enrolled and then followed at 3 monthly intervals over a 3 year period. All participants will be offered a 24 week course of Pegylated interferon alfa 2a which will be commenced within 12 weeks of screening.